InterCure Ltd. (INCR)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.57-1.72%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$70.1M

Revenue YoY

+23.9%

Net profit

$-17.0M

Net margin

-24.3%

Market cap

$75.5M

Forward P/E

6.2

P/B

0.62

Book value

$7.59

EPS (TTM)

$-0.95

52-week high

$8.10

52-week low

$3.40

50-day MA

$5.17

200-day MA

$4.65

Beta

0.64

with an average price target of $33.56.

Insiders

38.21%

Institutions

1.05%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InterCure Ltd. — free to start.

Data updated 2026-10-19.